Donor Safety in Obese Patients: 1038 Consecutive Robotic Living Donor Nephrectomies
1Surgery, University of Illinois, Chicago, IL
2Surgery, University of Virginia, Virginia, VA.
Meeting: 2018 American Transplant Congress
Abstract number: 532
Keywords: Donation, Nephrectomy, Obesity, Surgical complications
Session Information
Session Name: Concurrent Session: Kidney Living Donation: Programmatic Issues
Session Type: Concurrent Session
Date: Tuesday, June 5, 2018
Session Time: 4:30pm-6:00pm
Presentation Time: 5:06pm-5:18pm
Location: Room 6B
Laparoscopic donor nephrectomy has been a widely accepted technical improvement in kidney transplantation. Since 2000, we have introduced robotic living donor nephrectomy (RLDN) in our clinical practice which is characterized by high prevalence of obesity.
1038 RLDNs were reviewed retrospectively, from 2000 to 2016 in our Center. Donors were divided into 4 groups according to their BMI: <25 (group1-23.5%); 25-29.9 (group2-35.6%); 30-34.9 (group3-26.2%) and ≥35 (group4-14.6%).
Mean donor BMI was 29.32±5.98 with a predominance of male living related donors. 40.8% were morbidly obese(BMI>30). The majority underwent left nephrectomy (95%); multiple arteries were present in 24 cases (2%). Mean surgical time was 164±40 min with a warm ischemia time of 172±92 sec. On average the hospitalization was 2.8 days. Conversion to open was required in 5 cases (for major bleeding and malfunctioning staplers). All the conversions occurred early in the experience (the last one 11 years ago). Perioperative complications occurred in 10.2% of the cases and the majority were minor (Grade I-II) with the exception of 1 death, non-related to technical issues. There were no statistical differences in the 4 groups on surgical outcomes and postoperative complications.
Group 1 | Group 2 | Group 3 | Group 4 | p-value | |
Surgical time (min) mean±SD | 160.5±38.4 | 158.4±41.7 | 157.8±43.7 | 163.2±44.5 | 0.07 |
Warm Ischemia time (sec) mean±SD | 160.71±87.9 | 168.0±82.5 | 186.5±175.0 | 166.4±85.8 | 0.10 |
Length of Stay (days) mean±SD | 2.7±1.2 | 2.8±2.9 | 2.9±1.7 | 2.6±0.9 | 0.42 |
Peri-operative complications (N) | 20 | 38 | 24 | 18 | 0.97 |
Clavien-Dindo grade: | |||||
I | 8 | 28 | 13 | 8 | |
II | 5 | 6 | 9 | 5 | |
IIIa | 0 | 1 | 0 | 1 | |
IIIb | 6 | 3 | 2 | 4 | |
IV | 0 | 0 | 0 | 0 | |
V | 1 | 0 | 0 | 0 |
Recipients' outcomes were excellent with 1-year patient and graft survival of 97.6% and 95.8%, respectively.
RLDN is a reasonable alternative to conventional laparoscopy. The robotic technique allows successful procedures without additional morbidity in otherwise suitable obese donors.
CITATION INFORMATION: Di Bella C., Spaggiari M., Tulla K., Di Cocco P., Oberholzer J., Tzvetanov I., Benedetti E. Donor Safety in Obese Patients: 1038 Consecutive Robotic Living Donor Nephrectomies Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:
Bella CDi, Spaggiari M, Tulla K, Cocco PDi, Oberholzer J, Tzvetanov I, Benedetti E. Donor Safety in Obese Patients: 1038 Consecutive Robotic Living Donor Nephrectomies [abstract]. https://atcmeetingabstracts.com/abstract/donor-safety-in-obese-patients-1038-consecutive-robotic-living-donor-nephrectomies/. Accessed November 21, 2024.« Back to 2018 American Transplant Congress